576 related articles for article (PubMed ID: 8880851)
21. Effects of LY215490, a competitive alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid (AMPA) receptor antagonist, on the micturition reflex in the rat.
Yoshiyama M; Roppolo JR; de Groat WC
J Pharmacol Exp Ther; 1997 Feb; 280(2):894-904. PubMed ID: 9023304
[TBL] [Abstract][Full Text] [Related]
22. Effects of low-affinity NMDA receptor channel blockers in two rat models of chronic pain.
Medvedev IO; Malyshkin AA; Belozertseva IV; Sukhotina IA; Sevostianova NY; Aliev K; Zvartau EE; Parsons CG; Danysz W; Bespalov AY
Neuropharmacology; 2004 Aug; 47(2):175-83. PubMed ID: 15223296
[TBL] [Abstract][Full Text] [Related]
23. Role of glutamate receptors in the development and maintenance of bladder overactivity after cerebral infarction in the rat.
Yokoyama O; Mizuno H; Komatsu K; Akino H; Tanase K; Namiki M
J Urol; 2004 Apr; 171(4):1709-14. PubMed ID: 15017271
[TBL] [Abstract][Full Text] [Related]
24. Antinociceptive activity of the N-methyl-D-aspartate receptor antagonist N-(2-Indanyl)-glycinamide hydrochloride (CHF3381) in experimental models of inflammatory and neuropathic pain.
Villetti G; Bergamaschi M; Bassani F; Bolzoni PT; Maiorino M; Pietra C; Rondelli I; Chamiot-Clerc P; Simonato M; Barbieri M
J Pharmacol Exp Ther; 2003 Aug; 306(2):804-14. PubMed ID: 12750440
[TBL] [Abstract][Full Text] [Related]
25. Differential interaction of competitive NMDA and AMPA antagonists with selective dopamine D-1 and D-2 agonists in a rat model of Parkinson's disease.
Löschmann PA; Wüllner U; Heneka MT; Schulz JB; Kunow M; Wachtel H; Klockgether T
Synapse; 1997 Aug; 26(4):381-91. PubMed ID: 9215597
[TBL] [Abstract][Full Text] [Related]
26. Some behavioral effects of CNQX AND NBQX, AMPA receptor antagonists.
Maj J; Rogóz Z; Skuza G; Jaros T
Pol J Pharmacol; 1995; 47(4):269-77. PubMed ID: 8616504
[TBL] [Abstract][Full Text] [Related]
27. Tolerance to the cataleptic effect of the N-methyl-D-aspartate (NMDA) receptor antagonists in pigeons: cross-tolerance between PCP-like compounds and competitive NMDA antagonists.
Lu Y; France CP; Woods JH
J Pharmacol Exp Ther; 1992 Nov; 263(2):499-504. PubMed ID: 1432686
[TBL] [Abstract][Full Text] [Related]
28. NMDA-receptor blockers but not NBQX, an AMPA-receptor antagonist, inhibit spreading depression in the rat brain.
Nellgård B; Wieloch T
Acta Physiol Scand; 1992 Dec; 146(4):497-503. PubMed ID: 1283483
[TBL] [Abstract][Full Text] [Related]
29. Simultaneous blockade of non-NMDA ionotropic receptors and NMDA receptor-associated ionophore partially protects hippocampal slices from protein synthesis impairment due to simulated ischemia.
Virgili M; Contestabile A; Barnabei O
Hippocampus; 1995; 5(1):91-7. PubMed ID: 7787950
[TBL] [Abstract][Full Text] [Related]
30. MK-801 prevents the development of behavioral sensitization during repeated morphine administration.
Jeziorski M; White FJ; Wolf ME
Synapse; 1994 Feb; 16(2):137-47. PubMed ID: 8197575
[TBL] [Abstract][Full Text] [Related]
31. Antiallodynic and antihyperalgesic effects of selective competitive GLUK5 (GluR5) ionotropic glutamate receptor antagonists in the capsaicin and carrageenan models in rats.
Jones CK; Alt A; Ogden AM; Bleakman D; Simmons RM; Iyengar S; Dominguez E; Ornstein PL; Shannon HE
J Pharmacol Exp Ther; 2006 Oct; 319(1):396-404. PubMed ID: 16837561
[TBL] [Abstract][Full Text] [Related]
32. The effect of the AMPA/kainate receptor antagonist LY293558 in a rat model of postoperative pain.
Lee HJ; Pogatzki-Zahn EM; Brennan TJ
J Pain; 2006 Oct; 7(10):768-77. PubMed ID: 17018337
[TBL] [Abstract][Full Text] [Related]
33. Protective use of N-methyl-D-aspartate receptor antagonists as a spinoplegia against excitatory amino acid neurotoxicity.
Cho Y; Ueda T; Mori A; Shimizu H; Haga Y; Yozu R
J Vasc Surg; 2005 Oct; 42(4):765-71. PubMed ID: 16242566
[TBL] [Abstract][Full Text] [Related]
34. [Analgesic effects of ionotropic glutamate receptor antagonists MK-801 and NBQX on collagen-induced arthritis rats].
Zhu H; Zhu R; Deng ZD; Feng YC; Shen HL
Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Dec; 48(6):977-981. PubMed ID: 27987500
[TBL] [Abstract][Full Text] [Related]
35. The analgesic action of topical diclofenac may be mediated through peripheral NMDA receptor antagonism.
Dong XD; Svensson P; Cairns BE
Pain; 2009 Dec; 147(1-3):36-45. PubMed ID: 19766393
[TBL] [Abstract][Full Text] [Related]
36. Lack of effect of intrathecally administered N-methyl-D-aspartate receptor antagonists in a rat model for postoperative pain.
Zahn PK; Brennan TJ
Anesthesiology; 1998 Jan; 88(1):143-56. PubMed ID: 9447867
[TBL] [Abstract][Full Text] [Related]
37. N-methyl-D-aspartate receptor antagonists potentiate morphine's antinociceptive effect in the rat.
Grass S; Hoffmann O; Xu XJ; Wiesenfeld-Hallin Z
Acta Physiol Scand; 1996 Nov; 158(3):269-73. PubMed ID: 8931770
[TBL] [Abstract][Full Text] [Related]
38. Brain but not spinal NR2B receptor is responsible for the anti-allodynic effect of an NR2B subunit-selective antagonist CP-101,606 in a rat chronic constriction injury model.
Nakazato E; Kato A; Watanabe S
Pharmacology; 2005 Jan; 73(1):8-14. PubMed ID: 15452358
[TBL] [Abstract][Full Text] [Related]
39. Transient allodynia pain models in mice for early assessment of analgesic activity.
Gil DW; Cheevers CV; Donello JE
Br J Pharmacol; 2008 Feb; 153(4):769-74. PubMed ID: 17700719
[TBL] [Abstract][Full Text] [Related]
40. Pharmacology of spinal glutamatergic receptors in post-thermal injury-evoked tactile allodynia and thermal hyperalgesia.
Nozaki-Taguchi N; Yaksh TL
Anesthesiology; 2002 Mar; 96(3):617-26. PubMed ID: 11873037
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
